| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 85 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 85 |
| 2 | TACROLIMUS OINTMENT 0.1% | 85 |
| 3 | MYCOPHENOLATE MOFETIL | 83 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 83 |
| 5 | CYCLOSPORINE | 78 |
| 6 | FLUDARABINE PHOSPHATE | 58 |
| 7 | METHOTREXATE | 48 |
| 8 | METHOTREXATE SODIUM | 48 |
| 9 | PREDNISONE | 48 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BELUMOSUDIL | 13 | 0.0039 |
| 1 | TREOSULFAN | 8 | 0.0029 |
| 2 | BUSULFAN | 30 | 0.0019 |
| 3 | LETERMOVIR | 5 | 0.0015 |
| 4 | SIROLIMUS | 20 | 0.0015 |
| 5 | FLUDARABINE PHOSPHATE | 58 | 0.0015 |
| 6 | SODIUM HYALURONATE | 1 | 0.0012 |
| 7 | ASCIMINIB | 4 | 0.0011 |
| 8 | THIOTEPA | 10 | 0.0010 |
| 9 | GRANULOCYTE COLONY STIMULATING FACTOR | 2 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 96 |
| 1 | Calcineurin Inhibitor Immunosuppressant [EPC] | 78 |
| 2 | Kinase Inhibitor [EPC] | 66 |
| 3 | Alkylating Drug [EPC] | 56 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 48 |
| 5 | Janus Kinase Inhibitor [EPC] | 42 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 24 |
| 7 | mTOR Inhibitor Immunosuppressant [EPC] | 20 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 18 |
| 9 | Azole Antifungal [EPC] | 17 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 5 | 0.0015 |
| 1 | Calcineurin Inhibitor Immunosuppressant [EPC] | 78 | 0.0006 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 4 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 5 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 6 | Janus Kinase Inhibitor [EPC] | 42 | 0.0003 |
| 7 | Human alpha-1 Proteinase Inhibitor [EPC] | 1 | 0.0002 |
| 8 | Alkylating Drug [EPC] | 56 | 0.0002 |
| 9 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 4 | 0.0002 |